5:18 PM
 | 
Feb 14, 2014
 |  BC Extra  |  Company News

FDA postpones Northera decision

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) said late Friday that FDA delayed by one business day the PDUFA date for an NDA for Northera droxidopa to...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >